104 related articles for article (PubMed ID: 38953400)
1. Comment on "A systematic review and meta-analysis of herpes zoster occurrence/recurrence after COVID-19 infection and vaccination".
Kao CL; Liu PH
J Med Virol; 2024 Jul; 96(7):e29785. PubMed ID: 38953400
[No Abstract] [Full Text] [Related]
2. A systematic review and meta-analysis of herpes zoster occurrence/recurrence after COVID-19 infection and vaccination.
Wang F; Gao Y; Wagner AL; Lu Y
J Med Virol; 2024 May; 96(5):e29629. PubMed ID: 38682607
[TBL] [Abstract][Full Text] [Related]
3. Association of COVID-19 vaccination with herpes zoster: a systematic review and meta-analysis.
Chu CW; Jiesisibieke ZL; Yang YP; Wu PC; Lin HL; Tung TH
Expert Rev Vaccines; 2022 May; 21(5):601-608. PubMed ID: 35112938
[TBL] [Abstract][Full Text] [Related]
4. Understanding COVID-19 in Africa.
Tessema SK; Nkengasong JN
Nat Rev Immunol; 2021 Aug; 21(8):469-470. PubMed ID: 34168345
[TBL] [Abstract][Full Text] [Related]
5. Herpes zoster in the era of COVID 19: A prospective observational study to probe the association of herpes zoster with COVID 19 infection and vaccination.
Almutairi N; Almutairi AN; Almazyad M; Alwazzan S
Dermatol Ther; 2022 Jul; 35(7):e15521. PubMed ID: 35434963
[TBL] [Abstract][Full Text] [Related]
6. How COVID vaccines shaped 2021 in eight powerful charts.
Mallapaty S; Callaway E; Kozlov M; Ledford H; Pickrell J; Van Noorden R
Nature; 2021 Dec; 600(7890):580-583. PubMed ID: 34916666
[No Abstract] [Full Text] [Related]
7. Dynamic IgG seropositivity after rollout of CoronaVac and BNT162b2 COVID-19 vaccines in Chile: a sentinel surveillance study.
Sauré D; O'Ryan M; Torres JP; Zuniga M; Santelices E; Basso LJ
Lancet Infect Dis; 2022 Jan; 22(1):56-63. PubMed ID: 34509185
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 vaccination and treatment in vulnerable populations.
Delgoffe GM
Immunology; 2022 Feb; 165(2):141-142. PubMed ID: 35018636
[No Abstract] [Full Text] [Related]
9. Herpes zoster following vaccination with ChAdOx1 nCoV-19 Coronavirus vaccine (recombinant).
Job AM; Sudhamani B; Mohan M; Mohanasundaram SN
Indian J Public Health; 2022; 66(1):83-85. PubMed ID: 35381724
[TBL] [Abstract][Full Text] [Related]
10. Lessons Relearned? H1N1, COVID-19, and Vaccination Planning.
Fraser MR; Blumenstock J
J Public Health Manag Pract; 2021; 27 Suppl 1, COVID-19 and Public Health: Looking Back, Moving Forward():S106-S110. PubMed ID: 33239572
[No Abstract] [Full Text] [Related]
11. Varicella-Zoster virus reactivation following severe acute respiratory syndrome coronavirus 2 vaccination or infection: New insights.
Martinez-Reviejo R; Tejada S; Adebanjo GAR; Chello C; Machado MC; Parisella FR; Campins M; Tammaro A; Rello J
Eur J Intern Med; 2022 Oct; 104():73-79. PubMed ID: 35931613
[TBL] [Abstract][Full Text] [Related]
12. Association of herpes zoster with COVID-19 vaccination: A systematic review and meta-analysis.
Chen IL; Chiu HY
J Am Acad Dermatol; 2023 Aug; 89(2):370-371. PubMed ID: 37001732
[No Abstract] [Full Text] [Related]
13. Assessment of Herpes Zoster Risk Among Recipients of COVID-19 Vaccine.
Akpandak I; Miller DC; Sun Y; Arnold BF; Kelly JD; Acharya NR
JAMA Netw Open; 2022 Nov; 5(11):e2242240. PubMed ID: 36383382
[TBL] [Abstract][Full Text] [Related]
14. The effect of COVID-19 vaccine to the Omicron variant in children and adolescents: a systematic review and meta-analysis.
Lu W; Zeng S; Yao Y; Luo Y; Ruan T
Front Public Health; 2024; 12():1338208. PubMed ID: 38660347
[TBL] [Abstract][Full Text] [Related]
15. The era of SARS-CoV-2 variants calls for an urgent strategy for COVID-19 vaccination in children.
Li SM; Zhu FC
Lancet Infect Dis; 2024 Jul; 24(7):666-667. PubMed ID: 38518788
[No Abstract] [Full Text] [Related]
16. Herpes simplex, herpes zoster and periorbital erythema flares after SARS-CoV-2 vaccination: 4 cases.
Kluger N; Klimenko T; Bosonnet S
Ann Dermatol Venereol; 2022 Mar; 149(1):58-60. PubMed ID: 34711399
[No Abstract] [Full Text] [Related]
17. Beneficial effects of SARS-CoV-2 vaccination resulting from the COVID-19 pandemic with regard to the uptake of influenza virus, pneumococcal, and herpes zoster adult vaccination - a narrative literature review.
Kłoda K; Mierzecki A; Mastalerz-Migas A; Babicki M
Ann Agric Environ Med; 2023 Dec; 30(4):587-594. PubMed ID: 38153058
[TBL] [Abstract][Full Text] [Related]
18. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 vaccines and vaccination program for aging adults.
Chakraborty C; Sharma AR; Bhattacharya M; Agoramoorthy G; Lee SS
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(21):6719-6730. PubMed ID: 34787877
[TBL] [Abstract][Full Text] [Related]
20. Herpes zoster after COVID-19 vaccination-Can the vaccine reactivate latent zoster virus?
Palanivel JA
J Cosmet Dermatol; 2021 Nov; 20(11):3376-3377. PubMed ID: 34559453
[No Abstract] [Full Text] [Related]
[Next] [New Search]
